Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia - Wikidata - wikimedia - TriplyDB

Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia

Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia

http://www.wikidata.org/entity/Q24558647

about

Antiepileptic drugs and bone metabolism Comparison of metabolism of vitamins D2 and D3 in children with nutritional rickets Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease Evolutionary selection across the nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D, pregnane X, and constitutive androstane receptors).Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent Inflammatory conditions induce IRES-dependent translation of cyp24a1 A PXR-mediated negative feedback loop attenuates the expression of CYP3A in response to the PXR agonist pregnenalone-16α-carbonitrile Modeling of rifampicin-induced CYP3A4 activation dynamics for the prediction of clinical drug-drug interactions from in vitro data Pregnane X receptor and natural products: beyond drug-drug interactions Nutritional rickets around the world: an update.Vitamin d and rehabilitation: improving functional outcomes.Optimal vitamin D status for the prevention and treatment of osteoporosis.An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.Glucocorticosteroid-induced osteoporosis in adult primiparous Göttingen miniature pigs: effects on bone mineral and mineral metabolism.Stay tuned to PXR: an orphan actor that may not be D-structive only to bone.Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists.Low vitamin d status of patients in methadone maintenance treatment Association of 25-Hydroxyvitamin D Deficiency in Pediatric Epileptic Patients.A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics Vitamin D in organ transplantation Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.The mycoestrogen zearalenone induces CYP3A through activation of the pregnane X receptor.VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,0 Hyperforin, a new lead compound against the progression of cancer and leukemia?How dietary arachidonic- and docosahexaenoic- acid rich oils differentially affect the murine hepatic transcriptome.Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study.Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines.Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.Osteoporosis Associated with Epilepsy and the Use of Anti-Epileptics-a Review.Sesamin: A Naturally Occurring Lignan Inhibits CYP3A4 by Antagonizing the Pregnane X Receptor Activation.Organotypic liver culture models: meeting current challenges in toxicity testing.Influence of drugs on vitamin D and calcium metabolism Association between Vitamin D Receptor Gene Polymorphisms with Childhood Temporal Lobe Epilepsy.Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.The pregnane X receptor in tuberculosis therapeutics.Transcriptional regulation of the human pregnane-X receptor.Risk factors of vitamin D deficiency in children with epilepsy taking anticonvulsants at initial and during follow-up.Interplay between vitamin D and the drug metabolizing enzyme CYP3A4 A review of the effect of anticonvulsant medications on bone mineral density and fracture risk.Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats.

P2860

Q21245075-8904DB59-0662-4481-98E2-980AA10F05C9 Q24620233-C2A90B00-163E-4272-A647-F0D8BC35ABC5 Q24633922-4502D5A7-935E-4150-8E5B-EF811EF5BD99 Q24815571-9C87EB1E-4154-4124-80FF-ED97D837CC3C Q27485298-827B6593-F29D-4516-9FB1-B64C1555CAF8 Q28305723-4154FAA4-EEFD-411F-9C41-2A62B883B2DD Q28477056-21C0AD0D-35E9-47E8-9662-08AD7B18BC42 Q28533793-C5742AC3-02DD-4C11-9F88-EF403838F61C Q28748504-1BA4AD37-3307-4D39-8708-BEEB5D7947CD Q30240260-BAE6B697-0FFF-42C3-A9B2-D6DE0A2D64B8 Q30361740-C781AA27-E7C0-46FA-992F-71C71B2A53F6 Q30365934-172F3CFF-761E-42E6-AFC8-B4181750176B Q30511948-6D8ECBC2-A6F9-4911-92C9-9D363CB4BA5A Q33282690-4E274110-CBC4-4E3C-A589-651AC1505F4D Q33566132-B804CC63-F77B-414D-A1BB-99F663A1ADDA Q33756500-76474072-5ECF-44E6-BD2D-8B08C257B994 Q33763986-37BA05F6-2514-4226-A10E-3CF5DA290C21 Q33861621-E0812B76-FCF3-47B4-8DF6-995120C2353E Q33888821-C89CEA1C-647E-410D-9A13-76A11C95791E Q34069825-541BB8CF-701F-411C-A019-C78AF8049B78 Q34149359-96987337-811C-42AC-A0D5-85347DEA4865 Q34312427-DEAB0D4C-837D-4ADB-82B0-5A1F4FB2478E Q34517376-4E096E89-401D-4655-A2A0-A2163D6C04C5 Q34540807-15CAADBA-64B4-4B45-89F7-CCF190980089 Q34681828-0B26AE3D-4494-4EFE-B6B0-90D3911F4EFA Q34786514-23D0F927-2A51-4552-ABCD-5EC0EE39BA81 Q35076110-6F9170B3-E57C-4DE4-B23F-42F16F74CC74 Q35568534-C44DD86D-FAE0-4210-AE1C-C7D9E1676688 Q35924416-A78BAF8B-F0F7-4E7B-9125-5DA79EF56E30 Q35975156-6B1D2FDC-51A1-4854-A487-EF70EBE66A35 Q36178225-DE2EE411-B5ED-49F3-A198-99386268FF6A Q36187610-96D3E875-08FF-41CB-AD60-66953EE0B11C Q36324012-4C11DA91-F1E4-4598-BDDB-EE54A5E2C8E1 Q36440873-1D2130F2-790C-4FD9-8CCE-7DBD15EADD2F Q36451492-4983619B-D916-43F2-A8B3-36A35561DD54 Q36473472-3ED9B31A-321B-4B5A-AC01-7592A3378EAB Q36488565-DD806363-7416-40CE-A5A9-827C487176F9 Q36545257-D62ECDA4-2B87-450C-AEFF-2E426E034514 Q36605584-5F0360E8-FE7A-4FCF-855E-397F4CC87CF4 Q36650404-C4F8513D-1098-436C-A979-A26EBBB9BEC0

P2860

Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia

http://www.wikidata.org/entity/Q24558647

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Possible involvement of pregna ...... n in drug-induced osteomalacia

@ast

Possible involvement of pregna ...... n in drug-induced osteomalacia

@en

Possible involvement of pregna ...... n in drug-induced osteomalacia

@nl

type

label

Possible involvement of pregna ...... n in drug-induced osteomalacia

@ast

Possible involvement of pregna ...... n in drug-induced osteomalacia

@en

Possible involvement of pregna ...... n in drug-induced osteomalacia

@nl

prefLabel

Possible involvement of pregna ...... n in drug-induced osteomalacia

@ast

Possible involvement of pregna ...... n in drug-induced osteomalacia

@en

Possible involvement of pregna ...... n in drug-induced osteomalacia

@nl

P1433

Q24558647-D919CAF2-D16D-4979-81FE-538CEEB9B21C

P1476

Q24558647-31EB1AA1-DDF0-46ED-9AEF-DA809DADE600

P2093

Q24558647-1AE8FD65-FDF1-466C-9041-5DBB3FAD1F4E

Q24558647-31732A2C-98AA-4A9C-A78E-26B14705DE9E

Q24558647-3FB17DA0-D9B5-4306-8232-DE9F3A524896

Q24558647-51A363E0-ACDC-476B-A0D2-FF00004F01FB

Q24558647-5250EA58-DED8-40C7-81E2-77AE905AA36C

Q24558647-6A20A18C-C016-48FA-B723-A4DE14778AF7

Q24558647-76A051D7-3CD0-4E8E-AB74-5998B0CFEBA9

Q24558647-7C9A33CF-77E7-488F-A8C2-126D079E9A15

Q24558647-8FFB09C8-FB5C-4CEC-96E0-9EA1AA50FFE7

Q24558647-B8AB9FBE-983F-4056-9E8A-277E8F730D98

P2860

Q24558647-000806A1-DABC-4FC9-8E23-C24740D7C962

Q24558647-03CE62EA-9AD6-49BC-A852-6CE899B63E8A

Q24558647-0A64EDFF-90D2-44B0-B647-4935141C9E00

Q24558647-13DCFDD0-295A-4271-BA12-95E99B6DCA9B

Q24558647-14784362-E634-47A8-A52A-CF3B035DCA8E

Q24558647-18DD7186-E148-4F23-8E55-2CD2B8593F27

Q24558647-3BB7D0CD-AF3B-4162-83D3-3C11171F2524

Q24558647-41239A9A-C705-4E3A-BC20-0DBCB9AD5070

Q24558647-490DC9E9-A8FE-448A-BA9A-F739010BD042

Q24558647-4A0324E0-86C4-4F3E-86FC-148F5270128A

P304

Q24558647-AC694949-6B0E-4087-8462-0CA447D131C8

P31

Q24558647-E88E33B2-3CFD-4C53-96F9-7A4FCC5D3EE2

P356

Q24558647-F25FFE26-1FFA-4313-AEB5-6B7892472E1A

P407

Q24558647-DCDAEAD7-2B09-4487-9C9C-A1BF3BBA6DEC

P433

Q24558647-A85F2FBF-4747-4B07-BE86-1DC5B1C67264

P478

Q24558647-03D6326B-B49B-4C9D-91AE-6C509B4293F6

P577

Q24558647-03421442-462B-43B4-A772-08F2BB763693

P5875

Q24558647-6B335F82-0628-41CA-8F9E-60DEBF0E815D

P698

Q24558647-9121F06F-0AFF-4BA8-8D2D-5ADA0B49211F

P932

Q24558647-2EA1C38D-D570-49C3-92F8-ECA219320B86

P356

P1433

Journal of Clinical Investigation

P1476

Possible involvement of pregna ...... n in drug-induced osteomalacia

@en

P2093

Agnes Robert

http://www.w3.org/2001/XMLSchema#string

Fréderic Navarro

http://www.w3.org/2001/XMLSchema#string

Jean Marc Pascussi

http://www.w3.org/2001/XMLSchema#string

Jean Saric

http://www.w3.org/2001/XMLSchema#string

Marie Josè Vilarem

http://www.w3.org/2001/XMLSchema#string

Michèle Garabedian

http://www.w3.org/2001/XMLSchema#string

Minh Nguyen

http://www.w3.org/2001/XMLSchema#string

Odile Walrant-Debray

http://www.w3.org/2001/XMLSchema#string

Pascal Martin

http://www.w3.org/2001/XMLSchema#string

Patrick Maurel

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin D receptor as an intestinal bile acid sensor

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements

The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene

Calcitriol regulates the expression of the genes encoding the three key vitamin D3 hydroxylases and the drug-metabolizing enzyme CYP3A4 in the human fetal intestine

An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway

Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney

De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase

Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review).

P304

177-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI21867

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8101445

http://www.w3.org/2001/XMLSchema#string

P698

15630458

http://www.w3.org/2001/XMLSchema#string

P932

539191

http://www.w3.org/2001/XMLSchema#string